Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Design and synthesis of new tetrahydroquinolines derivatives as CETP inhibitors.

Escribano A, Mateo AI, Martin de la Nava EM, Mayhugh DR, Cockerham SL, Beyer TP, Schmidt RJ, Cao G, Zhang Y, Jones TM, Borel AG, Sweetana SA, Cannady EA, Mantlo NB.

Bioorg Med Chem Lett. 2012 Jun 1;22(11):3671-5. doi: 10.1016/j.bmcl.2012.04.042. Epub 2012 Apr 13.

PMID:
22543028
2.

Metabolism of LY654322, a growth hormone secretagogue, to an unusual diimidazopyridine metabolite.

Borel AG, Jones TM, Barbuch RJ, Jackson DA, Kulanthaivel P, Mattiuz E, Klimkowski VJ, Wheeler WJ, Rener GA.

Drug Metab Dispos. 2011 May;39(5):740-9. doi: 10.1124/dmd.110.037598. Epub 2011 Feb 23.

PMID:
21346003
3.

Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease.

Small DS, Wrishko RE, Ernest CS 2nd, Ni L, Winters KJ, Farid NA, Li YG, Brandt JT, Salazar DE, Borel AG, Kles KA, Payne CD.

J Clin Pharm Ther. 2009 Oct;34(5):585-94. doi: 10.1111/j.1365-2710.2009.01068.x.

PMID:
19744014
4.

Potent oxindole based human beta3 adrenergic receptor agonists.

Stevens FC, Bloomquist WE, Borel AG, Cohen ML, Droste CA, Heiman ML, Kriauciunas A, Sall DJ, Tinsley FC, Jesudason CD.

Bioorg Med Chem Lett. 2007 Nov 15;17(22):6270-3. Epub 2007 Sep 7.

PMID:
17911024
5.

Potent benzimidazolone based human beta(3)-adrenergic receptor agonists.

Finley DR, Bell MG, Borel AG, Bloomquist WE, Cohen ML, Heiman ML, Kriauciunas A, Matthews DP, Miles T, Neel DA, Rito CJ, Sall DJ, Shuker AJ, Stephens TW, Tinsley FC, Winter MA, Jesudason CD.

Bioorg Med Chem Lett. 2006 Nov 1;16(21):5691-4. Epub 2006 Aug 22.

PMID:
16931005
6.
10.
12.

Metabolic profiling of clobazam, a 1,5-benzodiazepine, in rats.

Borel AG, Abbott FS.

Drug Metab Dispos. 1993 May-Jun;21(3):415-27.

PMID:
8100496

Supplemental Content

Loading ...
Support Center